NcRNA-ROS regulate several cancer-related cell signalling pathways, such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), nuclear factor erythroid 2-related factor 2 (Nrf2), p53 phosphatase tensin homolog (PTEN), and the wingless (Wnt)/glycogen synthase kinase-3 beta (GSK3β) integration site. Here, NFE2L2 is linked to cancer.